Market Place
Sourcing Support
Amgen Presents New Data on Rare Inflammatory Diseases at ACR 2024
14 Nov 2024 //
PR NEWSWIRE
Amgen dismisses bone density concerns to its weight-loss drug
14 Nov 2024 //
REUTERS
BMS, Merck, Amgen & more face near-term generic woes: Leerink
13 Nov 2024 //
FIERCE PHARMA
Amgen, AZ`s Tezspire excels in phase 3 rhinosinusitis trial
09 Nov 2024 //
FIERCE PHARMA
AMGEN TO PRESENT AT THE 2024 UBS GLOBAL HEALTHCARE CONFERENCE
08 Nov 2024 //
PR NEWSWIRE
Amgen reaps Horizon buyout rewards in Q3, preps biosim launches
31 Oct 2024 //
FIERCE PHARMA
Amgen Whets Investors’ Appetites for MariTide Obesity Data by EoY
31 Oct 2024 //
BIOSPACE
Amgen disappears lung disease program after phase 2 fail
31 Oct 2024 //
FIERCE BIOTECH
AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
30 Oct 2024 //
PR NEWSWIRE
Amgen gears up to launch Eylea biosim as Regeneron plots appeal
23 Oct 2024 //
FIERCE PHARMA
AMGEN Presents Phase 3 Data For UPLIZNA® In Generalized Myasthenia
15 Oct 2024 //
PR NEWSWIRE
Amgen can`t sidestep investor lawsuit over $10.7B tax bill
02 Oct 2024 //
FIERCE PHARMA
La La Anthony Partners With Amgen on Plaque Psoriasis Insight
01 Oct 2024 //
PR NEWSWIRE
Amgen must face lawsuit claiming it hid $10.7 billion tax bill
01 Oct 2024 //
REUTERS
Amgen scores late trial success for eczema and MG treatments
25 Sep 2024 //
STATNEWS
Regeneron loses bid to block Amgen`s Eylea biosim, sinking shares
24 Sep 2024 //
FIERCE PHARMA
Amgen gets early win in Regeneron lawsuit over Eylea biosimilar
23 Sep 2024 //
REUTERS
Amgen And Merck Join Academic Clinical Trial Diversity Initiative
16 Sep 2024 //
FIERCE BIOTECH
AMGEN TO PRESENT DATA FROM MULTIPLE EARLY-STAGE CLINICAL TRIALS AT ESMO 2024
13 Sep 2024 //
PR NEWSWIRE
Viridian`s Drug Resolves Eye Disease Symptoms, Challenges Amgen`s Tepezza
11 Sep 2024 //
FIERCE BIOTECH
Big Pharma Backs OAC`s `Your Weight Matters` Campaign Challenge
10 Sep 2024 //
FIERCE PHARMA
Amgen Shares New Imdelltra Data In Small Cell Lung Cancer At WCLC 2024
09 Sep 2024 //
PR NEWSWIRE
Amgen Plans Phase III Program for Next-Gen Obesity Drug Targeting Liver and Kidney Diseases
06 Sep 2024 //
BIOSPACE
AMGEN TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE
29 Aug 2024 //
PR NEWSWIRE
BioMarin Brings on Roche, Amgen Alums in Executive Restructuring
22 Aug 2024 //
BIOSPACE
Roche Regains Reputation Crown Among Rare Disease Patient Groups
20 Aug 2024 //
FIERCE PHARMA
OTEZLA Now Available In US For Pediatric Plaque Psoriasis
20 Aug 2024 //
PR NEWSWIRE
Amgen`s Biologic Repatha (Evolocumab) Receives Suppl Approvals in US
19 Aug 2024 //
FDA
Amgen`s Biologic Amjevita (Adalimumab) Receives Suppl Approvals in US
19 Aug 2024 //
FDA
Biden, Harris hail Medicare drug price cuts that will save billions
16 Aug 2024 //
REUTERS
Amgen sues Samsung biotech unit over bone drug copies
14 Aug 2024 //
REUTERS
FDA Approved Amgen`s Imdelltra Despite Missing Adverse Event Data
13 Aug 2024 //
FIERCE PHARMA
5 Obesity Readouts to Watch in the Second Half of 2024
09 Aug 2024 //
BIOSPACE
Amgen Plans Technology & Innovation Centre In Hyderabad
09 Aug 2024 //
INDIANPHARMAPOST
Amgen`s marketing efforts help boost Tepezza sales
07 Aug 2024 //
FIERCE PHARMA
Amgen quarterly profit slips, obesity data on track for late 2024
06 Aug 2024 //
REUTERS
AMGEN REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS
06 Aug 2024 //
PR NEWSWIRE
AMGEN ANNOUNCES 2024 THIRD QUARTER DIVIDEND
02 Aug 2024 //
PR NEWSWIRE
Pharma Less Concerned After US Update On Medicare Negotiated Prices
29 Jul 2024 //
REUTERS
Immunex`s Biologic Enbrel(Etanercept) Receives Suppl Approval in US
22 Jul 2024 //
FDA
Amgen`s Wezenla (ustekinumab) Receives Approval in Europe
18 Jul 2024 //
EMA
J&J’s CAR-T partner Legend Biotech reportedly receives buyout offer
16 Jul 2024 //
FIERCE PHARMA
In boost to Amgen, analysts predict osteoporosis market share shift
28 Jun 2024 //
FIERCE PHARMA
US FDA approves Roche`s drug for a chronic blood disorder
22 Jun 2024 //
REUTERS
Amgen nabs new Blincyto approval for certain type of leukemia
17 Jun 2024 //
ENDPTS
Amgen Biologic Blinatumomab Receives Suppl Approval in US
14 Jun 2024 //
FDA
FDA Approves BLINCYTO For CD19-Positive Ph-Negative B-ALL
14 Jun 2024 //
PR NEWSWIRE
Amgen’s trial brings new hope for IgG4-RD patients
06 Jun 2024 //
PHARMATIMES
Amgen`s drug meets main goal in late-stage study for rare disease
06 Jun 2024 //
REUTERS
Amgen: Positive Uplizna Phase 3 Trial In Immunoglobulin G4-Related Disease
05 Jun 2024 //
PR NEWSWIRE
US FDA approves Amgen`s biosimilar to AZ`s rare blood disorder treatment
29 May 2024 //
REUTERS
Amgen: Oncology Research Highlights At ASCO 2024
28 May 2024 //
PR NEWSWIRE
FDA Approves First Interchangeable Biosimilar for Two Rare Diseases
28 May 2024 //
PR NEWSWIRE
Amgen 1Q Results
21 May 2024 //
CONTRACT PHARMA
US FDA approves two biosimilars for blockbuster eye drug Eylea
21 May 2024 //
REUTERS
US FDA approves Amgen drug for small cell lung cancer
17 May 2024 //
REUTERS
Amgen`s Biologic mdelltra (tarlatamab-dlle) Receives Approval in the U.S.
16 May 2024 //
FDA
FDA Approves Imdelltra, First T-Cell Engager For Extensive SCLC
16 May 2024 //
PR NEWSWIRE
AMGEN TO HOST CONFERENCE CALL FOLLOWING ATS 2024
15 May 2024 //
PR NEWSWIRE
CytomX shares plummet as Amgen-partnered cancer drug yields jumbled Phase 1 data
09 May 2024 //
ENDPTS
